Clinical trial of Manjishtha Kwath in painful menstruation

A single arm clinical trial of Manjishtha Kwath in udavartini yonivyapad w.s.r. to primary dysmenorrhea

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/07/043732

Enrollment

100

Registered

2022-07-05

Start date

Unknown

Completion date

Unknown

Last updated

2022-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N944- Primary dysmenorrhea

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1)female patients of age group 13-19 years 2) Patients with Primary Dysmenorrhoea 3) Diagnosed patients of Udavartini Yoniyapad according to symptoms. 4) Unmarried Female Patients

Exclusion criteria

Exclusion criteria: 1) Patients of Secondary dysmenorrhoea 2) Married Female Patients 3) Patients with K/H/O fibroid, endometriosis, adenomyosis 4) K/H/O congenital anamolies of pelvic reproductive organ 5) K/H/O Oligomenorrhoea, PCOS, puberty menorrhagia

Design outcomes

Primary

Measure	Time frame
1. To reduce the severity and incidence of pain during the menses 2. To assess the pain with the help of VAS-SCALE 3. To improve quality of life 4. To reduce the incidence and severity of pain 5. To study in detail the nidana, samprapti of udavartini yonivyapad and etiopathogenesis of primary dysmenorrhea 6. To assess the improvement in the udavartini yonivyapad after treatment of 3 cyclesTimepoint: 3 months	—

Measure

Time frame

1. To reduce the severity and incidence of pain during the menses 2. To assess the pain with the help of VAS-SCALE 3. To improve quality of life 4. To reduce the incidence and severity of pain 5. To study in detail the nidana, samprapti of udavartini yonivyapad and etiopathogenesis of primary dysmenorrhea 6. To assess the improvement in the udavartini yonivyapad after treatment of 3 cyclesTimepoint: 3 months

—

Secondary

Measure	Time frame
1. To reduce the severity and incidence of pain during the menses . 2. VAS-SCALE 3. To improve quality of life. 4. Incidance and severity of pain can be reduced. 5. To study in detail the nidana, samprapti of Udavartini Yonivyapad and etiopathogenesis of primary dysmenorrhoea 6. To assess the improvement in the Udavartini Yonivyapad after treatment 7. To achieve improvement in Udavartini Yonivyapad in a span of 4 months Timepoint: 3months	—

Measure

Time frame

1. To reduce the severity and incidence of pain during the menses . 2. VAS-SCALE 3. To improve quality of life. 4. Incidance and severity of pain can be reduced. 5. To study in detail the nidana, samprapti of Udavartini Yonivyapad and etiopathogenesis of primary dysmenorrhoea 6. To assess the improvement in the Udavartini Yonivyapad after treatment 7. To achieve improvement in Udavartini Yonivyapad in a span of 4 months Timepoint: 3months

—

Countries

India

Contacts

Public ContactDr Vishala Turlapati

Yashwant Ayurvedic mahavidyalaya and research centre kodoli

vishalaturlapati@gmail.com9960217429

Outcome results